| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 1638763-75-3 | tert-Butyl 4-oxo-3-(2,2,2-trifluoroethyl)-piperidine-1-carboxylate | C12H18F3NO3 |
| 1638763-87-7 | 6-Chloro-1H-pyrrolo[2,3-b]pyridin-4-ol | C7H5ClN2O |
| 1638767-22-2 | N-(1-methyl-2-oxo-4-piperidinyl)-Carbamic acid 1,1-dimethylethyl ester | C11H20N2O3 |
| 1638767-25-5 | N-(3-Aminobicyclo[1.1.1]pent-1-yl)carbamic acid 1,1-dimethylethyl ester | C10H18N2O2 |
| 1638771-94-4 | 2-[1,1-Dimethyl-2-(phenylmethoxy)ethyl]-6-fluoro-5-nitro-1H-indole | C19H19FN2O3 |
| 1638772-21-0 | 4-Bromo-2-methyl-2H-indazole-6-carboxylic acid methyl ester | C10H9BrN2O2 |
| 1638784-10-7 | 6-(2-((3,6,8-Trisulfopyren-1-yl)oxy)acetamido)hexanoic acid | C24H23NO13S3 |
| 1639042-08-2 | (E)-3-[3,5-Difluoro-4-[(1R,3R)-2-(2-fluoro-2-methylpropyl)-3-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl]phenyl]acrylic acid | C25H25F3N2O2 |
| 1639137-80-6 | 2-[[1-Acetyl-3-[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]thio]-N-methylbenzamide | C24H20N4O2S |
| 1639138-00-3 | Axitinib Impurity | C17H14IN3O2S |
| 1639208-54-0 | Valbenazine tosylate | C24H38N2O4.2(C7H8O3S) |
| 1639257-36-5 | 8(17),12E,14-Labdatrien-20-oic acid | C20H30O2 |
| 1639257-37-6 | 12E,14-Labdadien-20,8beta-olide | C20H30O2 |
| 1639263-80-1 | Vortioxetine Impurity 25 | C18H22N2O2S |
| 1639296-49-3 | 6-Bromo-5-chlorobenzo[b]thiophene-2-carboxylic acid methyl ester | C10H6BrClO2S |
| 1639324-58-5 | Cemdisiran | C78H140N11O34P |
| 1639325-43-1 | Givosiran | C78H139N11O30 |
| 1639351-92-0 | Mc-Val-Cit-PAB-Cl | C28H39ClN6O6 |
| 1639454-74-2 | trans-2-((tert-Butoxycarbonyl)amino)-1-fluorocyclobutane-1-carboxylicacid | C10H16FNO4 |
| 1639454-84-4 | (1R,2R)-2-{[(tert-butoxy)carbonyl]amino}-1-fluorocyclobutane-1-carboxylic acid | C10H16FNO4 |
| 1639866-72-0 | 3-Amino-5-ethynylbenzoic acid | C9H7NO2 |
| 1639970-62-9 | Sacubitril Impurity 57 | C22H23NO4 |
| 1640282-31-0 | 1-[7-(3,4-Dimethoxyphenyl)-2,3-dihydro-9-[[(3S)-1-methyl-3-piperidinyl]methoxy]-1,4-benzoxazepin-4(5H)-yl]-1-propanone | C27H36N2O5 |
| 1640292-55-2 | trans-N-Methyl-4-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)cyclohexanemethanesulfonamide (2Z)-2-butenedioate (1:1) | C15H23N5O2S.C4H4O4 |
| 1640971-87-4 | Tofacitinib Related Compound 2 HCl | C10H18ClN3O |
| 1640972-35-5 | Tofacitinib Impurity | C16H22N6O |
| 1640981-19-6 | 4-Hydroxy-2-methyl-1-(phenylmethyl)-1H-benzimidazole-6-carboxylic acid | C16H14N2O3 |
| 1642288-47-8 | Mavacamten | C15H19N3O2 |
| 1642298-59-6 | 3-(Fluoromethyl)azetidine hydrochloride | C4H9ClFN |
| 1642303-38-5 | Lenrispodun phosphate | C29H29FN7O5P |
| 1642308-34-6 | 2,6-Bis[4-(9H-carbazol-9-yl)phenyl]-9,10-anthracenedione | C50H30N2O2 |
| 1642330-72-0 | 2-(Biphenyl-4-yl)-4-(4-chlorophenyl)-6-phenyl-1,3,5-triazine | C27H18ClN3 |
| 1642330-94-6 | Rosuvastatin Impurity 41 | C15H26O6 |
| 1642542-05-9 | 1-Bromo-5-chloro-3-fluoro-2-nitrobenzene | C6H2BrClFNO2 |
| 1642571-08-1 | tert-Butyl (S)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate | C27H30N6O3 |
| 1642630-12-3 | 3-(4-Phenoxyphenyl)-1-(3S)-3-piperidinyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine | C22H22N6O |
| 1642853-67-5 | N-[(2,3-Dihydro-1-methyl-2-oxo-1H-benzimidazol-5-yl)carbonyl]-N-2-pyridinyl-beta-alanine ethyl ester | C19H20N4O4 |
| 1642873-03-7 | N-Propylsulfamide sodium salt | C3H9N2O2SNa |
| 1643141-20-1 | 1-Methyl-3-[(methylamino)methyl]-1H-pyrazole-5-carbonitrile hydrochloride (1:1) | C7H10N4.HCl |
| 1643156-18-6 | 4-Bromo-5-fluoro-2-hydrazinylbenzoic acid hydrochloride | C7H6BrFN2O2.HCl |
| 1643330-62-4 | 5-Chloro-N-[4-[5,6-dihydro-3-(4-morpholinyl)-2-oxo-1(2H)-pyridinyl]phenyl]pentanamide | C20H26ClN3O3 |
| 1643377-48-3 | 2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-N-(3-amino-3-oxopropyl)-1-methyl-N-2-pyridinyl-1H-benzimidazole-5-carboxamide | C25H26N8O2 |
| 1643378-47-5 | (1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(4-Fluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-1,2-cyclopentanediol | C23H29FN6O4S |
| 1643378-48-6 | (1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(2,3-Difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-1,2-cyclopentanediol | C23H28F2N6O4S |
| 1643479-47-3 | 9-[1,1'-Biphenyl]-3-yl-9'-[1,1'-biphenyl]-4-yl-3,3'-bi-9H-carbazole | C48H32N2 |
| 1643526-99-1 | 3-([1,1'-Biphenyl]-3-yl)-9H-carbazole | C24H17N |
| 1643678-96-9 | 9-(4-Dibenzofuranyl)-9H-fluoren-9-ol | C25H16O2 |
| 1643684-05-2 | Atomoxetine EP Impurity D | C17H21NO .HCl |
| 1643684-06-3 | Atomoxetine EP Impurity C | C17H22ClNO |
| 1643848-13-8 | 4-(2-Benzoxazolyl)-N-phenylbenzenamine | C19H14N2O |